このアイテムのアクセス数: 6653

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
56_351.pdf617.35 kBAdobe PDF見る/開く
タイトル: 抗血小板薬の術後再開時期についての検討: 泌尿器科手術患者を対象としたProspective study
その他のタイトル: Early Initiation of Antiplatelet Therapy after Urological Surgery : A Prospective Study
著者: 藤田, 昌弘  KAKEN_name
大年, 太陽  KAKEN_name
小林, 憲市  KAKEN_name
福本, 亮  KAKEN_name
今村, 亮一  KAKEN_name
高田, 晋吾  KAKEN_name
松宮, 清美  KAKEN_name
藤岡, 秀樹  KAKEN_name
著者名の別形: Fujita, Masahiro
Otoshi, Taiyo
Kobayashi, Kenichi
Fukumoto, Ryo
Imamura, Ryoichi
Takada, Shingo
Matsumiya, Kiyomi
Fujioka, Hideki
キーワード: Antiplatelet drugs
Urological surgery
発行日: Jul-2010
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 56
号: 7
開始ページ: 351
終了ページ: 354
抄録: In recent times, the number of patients receiving antiplatelet drugs for the prevention of cardiovascular and cerebrovascular diseases has been increasing. We examined the possibility of early initiation of antiplatelet therapy after urological operations. Between April 2008 and February 2009, 62 patients who received antiplatelet drugs and underwent urological surgeries (open surgery, transurethral surgery and laparoscopic surgery) and prostate biopsies were examined. Of the 62 patients, 59 were randomized into 2 groups ; 32 patients receiving antiplatelet treatment initiation within 24 hours (early group) and 29 patients receiving this treatment more than 24 hours (late group) after the urological operation. The end point of this study was the re-cessation of antiplatelet therapy because of the development of postoperative complications (hematuria, blood loss, etc.) and cardiovascular and cerebrovascular events within 1 month. There was no significant difference in the urological events observed between these groups, including 2 of the 32 (6.3%) patients in the early group and 3 of the 27 (11.1%) in the late group. Cardiovascular and cerebrovascular diseases were not noted in any of the patients within 1 month. In conclusion, we think that it is possible to initiate antiplatelet therapy within 24 hours after urological operations and prostate biopsies in the absence of active blood loss. Early initiation may prevent the risk of cardiovascular and cerebrovascular disease in the future.
著作権等: 許諾条件により本文は2011-08-01に公開
URI: http://hdl.handle.net/2433/123439
PubMed ID: 20724806
出現コレクション:Vol.56 No.7

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。